DSP Clinical Announces New Co-Monitoring Service
DSP Clinical, a full-service CRO managing Phase I to IV clinical trials across many therapeutic areas including infertility, endocrinology, urology, and gastrointestinal studies, announced a new co-monitoring service that provides flexible, cost-effective monitoring support to help clinical trials meet study timelines.
The service, which scales to fit the size, complexity, and speed of Phase I–IV research clinical trials in any therapeutic area, can provide back-up monitors who are trained and ready to help. DSP monitors are long-term CCRA-certified employees who are fluent in a variety of EDC systems.
Sponsors can elect to have full- or part-time monitoring help with tasks such as reviewing data, conducting pre-study visits, or preparing for site audits. DSP’s monitors step in as needed, working as an extension of the existing study team while minimizing overhead and lag time. The service is available immediately.
For more information, visit dspclinical.com
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.
